Development of MR Nanoprobing Technique for Non-Small CellLung Cancer to Achieve Simultaneous Imaging and Drug Delivery
碩士 === 國立臺灣大學 === 生醫電子與資訊學研究所 === 99 === Molecular imaging is the technology that combined molecular biology and clinical medicine in the biomedical field. The goal of this study is to develop a bi-functional contrast agent used in magnetic resonance image (MRI) to achieve the simultaneous imaging a...
Main Authors: | Chia-Hsin Pan, 潘佳欣 |
---|---|
Other Authors: | 陳志宏 |
Format: | Others |
Language: | en_US |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/06039089293487316715 |
Similar Items
-
Ganoderma Triterpenoid GC538 Enhances AnticancerActivity of Gefitinib in Drug-resistant Non-small-cellLung Cancer Cell Line
by: Chih-Hsuan Kuo, et al.
Published: (2013) -
Kotomolide A arrests cell cycle progression and induces apoptosis in human non-small celllung cancer A549 cells
by: Yu-Chieh Tsai, et al.
Published: (2010) -
Development of MR Nanoprobing for Non-Small Cell Lung Cancer:The Application of EGFR Antibody Conjugated Fe3O4 Nanoparticles
by: Wei-Ting Lin, et al.
Published: (2006) -
Eu-Doped Citrate-Coated Carbonated Apatite Luminescent Nanoprobes for Drug Delivery
by: Ylenia Jabalera, et al.
Published: (2020-01-01) -
Enhanced photoacoustic effect for simultaneous imaging and drug release using phase-transition mesoporous silicon nanoprobe
by: Junping Zhong, et al.
Published: (2021-07-01)